Navigation Links
Nanotech and synbio: Americans don't know what's coming
Date:9/29/2008

Washington, DC A groundbreaking poll finds that almost half of U.S. adults have heard nothing about nanotechnology, and nearly nine in 10 Americans say they have heard just a little or nothing at all about the emerging field of synthetic biology, according to a new report released by the Project on Emerging Nanotechnologies (PEN) and Peter D. Hart Research. Both technologies involve manipulating matter at an incredibly small scale to achieve something new.

This new insight into limited public awareness of emerging technologies comes as a major leadership change is about to take hold in the nation's capital. Public policy experts are concerned, regardless of party, that the federal government is behind the curve in engaging citizens on the potential benefits and risks posed by technologies that could have a significant impact on society.

"Early in the administration of the next president, scientists are expected to take the next major step toward the creation of synthetic forms of life. Yet the results from the first U.S. telephone poll about synthetic biology show that most adults have heard just a little or nothing at all about it," says PEN Director David Rejeski. The poll findings are contained a report published today, The American Public's Awareness Of And Perceptions About Potential Risks and Benefits of Nanotechnology & Synthetic Biology, and available at: www.nanotechproject.org/n/synbio_poll . This page is limited access until the embargo is lifted. Login: synbio Password: advance

Synthetic biology is the use of advanced science and engineering to construct or re-design living organismslike bacteriaso that they can carry out specific functions. This emerging technology is likely to develop rapidly in the coming years, much as nanotechnology did in the last decade. In the near future the first synthetic biology "blockbuster" drug is anticipated to hit the marketan affordable treatment for the 500 million people in the world suffering from malaria.

The poll, which was conducted by the same firm that produces the well-known NBC News/Wall Street Journal polls, found that about two-thirds of adults say they have heard nothing at all about synthetic biology, and only 2 percent say they have heard "a lot" about the new technology. Even with this very low level of awareness, a solid two-thirds of adults are willing to express an initial opinion on the potential benefits versus risks tradeoff of synthetic biology.

This survey was informed by two focus groups conducted in August in suburban Baltimore. This is the first timeto the pollsters' knowledgethat synthetic biology has been the subject of a representative national telephone survey.

At the same time, the poll found that about half of adults say they have heard nothing at all about nanotechnology. About 50 percent of adults are too unsure about nanotechnology to make an initial judgment on the possible tradeoffs between benefits and risks. Of those people who are willing to make an initial judgment, they think benefits will outweigh risks by a three to one margin when compared to those who believe risks will outweigh benefits. The plurality of respondents, however, believes that risks and benefits will be about equal. A major industry forecasting firm determined that last year nanotech goods in the global marketplace totaled $147 billion. According to the poll, the level of U.S. public awareness about nanotechnology has not changed measurably since 2004 when Hart Research conducted the first poll on the topic on behalf of the PEN.


'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Related biology news :

1. Save-the-date: Major nanotech, energy, and biomed meeting
2. Nanotechnology: A brave new world requires bold new research approaches
3. NSF and EPA establish 2 centers for environmental implications of nanotechnology
4. UCLA, partners establish new center on environmental effects of nanotechnology
5. Duke to lead new NSF, EPA center to study the environmental implications of nanotechnology
6. NSF funds multi-university center to study environmental implications of nanotechnology
7. Halas wins prestigious nanotechnology research award
8. Air-purifying church windows early nanotechnology
9. Scientists overcome nanotech hurdle
10. Study shows increased education on nanotech, human enhancement increases public concerns
11. Emergency response and nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... -- WearablesResearch.com , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... published their findings on what they believe could be a new and helpful ... the new research. Click here to read it now. , Biomarkers ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology: